As of Apr 29
| -0.02 / -1.52%|
The 4 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +169.23% increase from the last price of 1.30.
The current consensus among 5 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.